# DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)

> **NCT07398066** · NA · NOT_YET_RECRUITING · sponsor: **University of Malaya** · enrollment: 60 (estimated)

## Conditions studied

- Neurosurgery
- Brain Cancer
- Meningioma

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Normal Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07398066
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-22
- **Primary completion:** 2027-07-22
- **Final completion:** 2027-08-22
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07398066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07398066, "DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07398066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*